DOIAbstract
In a recent report published in PNAS, Gellman and coworkers describe the design, characterization, and potent activity of α/β-peptides that mimic a long α helix involved in HIV viral entry
In a recent report published in PNAS, Gellman and coworkers describe the design, characterization, and potent activity of α/β-peptides that mimic a long α helix involved in HIV viral entry
A new class of peptidomimetics termed as γ-AApeptides was recently developed by our group. Similar...
With the emergence of novel viruses, the development of new antivirals is more urgent than ever. A k...
AbstractTreatment of HIV has long faced the challenge of high mutation rates leading to rapid develo...
In a recent report published in PNAS, Gellman and coworkers describe the design, characterization, a...
SummaryA variety of molecules in human blood have been implicated in the inhibition of HIV-1. Howeve...
MasterCuring HIV infection has remained a difficult goal due to low drug absorption, drug toxicity, ...
AbstractThe HIV-1 gp41 protein promotes viral entry by mediating the fusion of viral and cellular me...
The HIV gp41 N-trimer pocket region is an ideal viral target because it is extracellular, highly con...
© 2018 Bentham Science PublishersBackground: Few HIV-1fusion and replication inhibitors were develop...
HIV-1 integrase (IN) is an enzyme which is indispensable for the stable infection of host cells beca...
Motivation: The need for more effective and safer pharmaceuticals is a persistent quest. Microbial a...
The HIV-1 pandemic is one of the most serious health problems facing the world today. Infection of t...
Oral presentations Background: We selected peptide ligands for the HIV-1 packaging signal PSI by scr...
Human immunodeficiency virus type 2 (HIV-2) has already spread to different regions worldwide, and c...
The viral enzyme integrase (IN) is essential for the replication of human immunodeficiency virus typ...
A new class of peptidomimetics termed as γ-AApeptides was recently developed by our group. Similar...
With the emergence of novel viruses, the development of new antivirals is more urgent than ever. A k...
AbstractTreatment of HIV has long faced the challenge of high mutation rates leading to rapid develo...
In a recent report published in PNAS, Gellman and coworkers describe the design, characterization, a...
SummaryA variety of molecules in human blood have been implicated in the inhibition of HIV-1. Howeve...
MasterCuring HIV infection has remained a difficult goal due to low drug absorption, drug toxicity, ...
AbstractThe HIV-1 gp41 protein promotes viral entry by mediating the fusion of viral and cellular me...
The HIV gp41 N-trimer pocket region is an ideal viral target because it is extracellular, highly con...
© 2018 Bentham Science PublishersBackground: Few HIV-1fusion and replication inhibitors were develop...
HIV-1 integrase (IN) is an enzyme which is indispensable for the stable infection of host cells beca...
Motivation: The need for more effective and safer pharmaceuticals is a persistent quest. Microbial a...
The HIV-1 pandemic is one of the most serious health problems facing the world today. Infection of t...
Oral presentations Background: We selected peptide ligands for the HIV-1 packaging signal PSI by scr...
Human immunodeficiency virus type 2 (HIV-2) has already spread to different regions worldwide, and c...
The viral enzyme integrase (IN) is essential for the replication of human immunodeficiency virus typ...
A new class of peptidomimetics termed as γ-AApeptides was recently developed by our group. Similar...
With the emergence of novel viruses, the development of new antivirals is more urgent than ever. A k...
AbstractTreatment of HIV has long faced the challenge of high mutation rates leading to rapid develo...
Add to ORKG